ES457817A3 - A procedure for the obtaining of new then (2,3-e) (1,4) diacepin-2-onas. (Machine-translation by Google Translate, not legally binding)
- Google Patents
A procedure for the obtaining of new then (2,3-e) (1,4) diacepin-2-onas. (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide CorpfiledCriticalWelfide Corp
Priority to ES457817ApriorityCriticalpatent/ES457817A3/en
Publication of ES457817A3publicationCriticalpatent/ES457817A3/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
Procedure for obtaining new thieno [2,3-e] [1,4] diacepin-2-ones of formula I: *** 1 (See formula 1) in which R1 and R2 are each H or a lower alcohol with 1 to 4 carbon atoms; R3 is a lower alcohol with 1 to 4 carbon atoms, and R is halogen, CF3 or a lower alkoxy with 1 to 4 carbon atoms; as well as its pharmaceutically tolerable acid addition salts. (Machine-translation by Google Translate, not legally binding)
ES457817A1977-04-141977-04-14A procedure for the obtaining of new then (2,3-e) (1,4) diacepin-2-onas. (Machine-translation by Google Translate, not legally binding)
ExpiredES457817A3
(en)
Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -norosimorphone new. (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of new free bases of 4,5-dihydro-2-alcoxicarbonilamino-4-aril-imidazoles. (Machine-translation by Google Translate, not legally binding)